Lymphangiogenesis and colorectal cancer

Area of Science:

• Oncology
• Cancer Biology
• Pathology

Background:

• Lymphatic metastasis is a critical factor in colorectal cancer (CRC) progression.
• Increased lymphatic microvessel density (LMVD) is observed in peritumoral CRC tissues compared to normal tissues.

Purpose of the Study:

• To evaluate the significance of lymphangiogenesis in colorectal cancer.
• To explore the potential of targeting lymphangiogenesis as a therapeutic strategy for CRC.

Main Methods:

• Analysis of lymphatic microvessel density (LMVD) in colorectal cancer tissues.
• Review of signaling pathways (VEGF-C/VEGF-D/VEGFR-3, Shh) and extracellular matrix (ECM) involvement in lymphangiogenesis.
• Examination of experimental data on inhibiting tumor lymphangiogenesis and metastasis.

Main Results:

• Higher LMVD in CRC tissues correlates with disease-free survival (DFS) and local recurrence.
• The VEGF-C/VEGF-D/VEGFR-3 pathway, Shh signaling, and ECM are key regulators of CRC lymphangiogenesis.
• Inhibition of the VEGF pathway effectively reduced experimental tumor lymphangiogenesis and metastasis.

Conclusions:

• Lymphangiogenesis plays a significant role in colorectal cancer development and prognosis.
• While promising, the therapeutic potential of targeting lymphangiogenesis in CRC requires further investigation.